Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
1.
Int J Ophthalmol ; 16(12): 1996-2003, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-38111947

RESUMEN

AIM: To evaluate the effect of symmetrical arc incision correcting corneal astigmatism in femtosecond laser-assisted phacoemulsification (FLACS). METHODS: This study enrolled patients with cataract combined with regular corneal astigmatism of >0.75 D, who underwent FLACS. Symmetrical arc incision was set at 8 mm diameter and 85% depth. The follow-up time was 3-24mo (4.92±3.49mo). Pentacam recorded the corneal astigmatism and higher-order aberration at pre-operation and post-operation. The changes in corneal astigmatism were analyzed by Alpins method. The correlation of astigmatism type, age, corneal horizontal diameter, corneal thickness, arc incision length, and correction index (CI) was analyzed, and the residual corneal astigmatism was compared with the residual whole eye astigmatism. RESULTS: Totally 79 patients (102 eyes) were enrolled, 10 patients had corneal epithelial injury, 1 patient occurred corneal epithelial hyperplasia. The corneal astigmatism was 1.23±0.38 D pre-operation, and decreased to 0.76±0.39 D post-operation (t=10.146, P=0.000). Corneal high-order aberration was 0.17±0.08 µm pre-operation and 0.24±0.11 µm post-operation (t=-5.186, P=0.000). The residual corneal astigmatism and residual whole eye astigmatism were no significant difference (t=-0.347, P=0.729). Using Alpin's method, the following were determined: target-induced astigmatism (TIA) =1.23±0.38 D, surgery-induced astigmatism (SIA) =0.77±0.45 D, difference vector (DV)=0.77±0.39 D, and CI=0.54±0.28. Age, astigmatism size, corneal horizontal diameter, corneal thickness, and arc incision length were not correlated with CI. The CI for against the rule astigmatism (ATR) was better than that for with the rule astigmatism (WTR; P=0.001). CONCLUSION: Femtosecond laser-assisted astigmatic keratotomy has better CI of ATR, but increase higher-order corneal aberration. CI is not ideal, it's not a perfect choice if we pursue ideal correction effect.

2.
Am J Transl Res ; 15(3): 2065-2074, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-37056824

RESUMEN

OBJECTIVE: To characterize the clinical features of cataract surgery performed after refractive surgery. METHODS: In this study, 23 patients with cataracts (38 eyes) who underwent cataract surgery following refractive surgery at the Shenzhen Aier Eye Hospital between the years 2017 and 2021 were retrospectively included for analysis. The patients had either femtosecond laser-assisted cataract surgery (FLACS) combined with intraocular lens implantation (IOLI), or conventional phacoemulsification (Phaco) combined with IOLI. The type and power of an intraocular lens (IOL) were selected based on the ocular condition, needs, and living habits of patients. Intraoperative complications, postoperative intraocular pressure (IOP), uncorrected visual acuity (UCVA), and postoperative refractive status were all recorded and analyzed. RESULTS: The patients had a postoperative UCVA that was significantly better than the baseline (prior to operation), a postoperative IOP and diopter (D) similar to the baseline and a high level of postoperative satisfaction. The postoperative visual acuity, D and complication rate of FLACS+IOLI group were not significantly different from those of Phaco+IOLI group, and the IOP of the former was statistically lower than that of the latter. CONCLUSIONS: FLACS with IOLI or conventional Phaco with IOLI is feasible for cataract patients who have undergone refractive surgery. In terms of IOL selection, multifocal, extended range of vision (ERV), or trifocal types can be selected to achieve the goal of lens removal after surgery, but the decision should be made based on the patient's specific eye condition, living needs, and economic circumstances. To achieve satisfactory curative effects, it is necessary to have a comprehensive understanding of the characteristics of the condition of such patients, to master the pre- and post-operative diagnosis and treatment methods, to accurately calculate the IOLP, to fully communicate with patients about their surgical expectations, and to develop feasible surgical plans.

3.
Comput Math Methods Med ; 2021: 6084496, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34873416

RESUMEN

With an increasing incidence in recent years, glaucoma (GL) has gradually become a global public health problem for humans of all ages. Nerve growth factor (NGF) eye drops, with well-documented stable effect in the treatment of GL, can be potentiated by the administration of NGF drugs via ultrasound contrast agent (UCA). This study analyzed the efficacy of NGF+UCA on GL mice and the influencing mechanism on retinal ganglion cells and further explored the pathological changes of GL mice under different UCA irradiation duration. In this study, we established GL mouse models and treated the mouse with NGF+UCA. The effect of NGF+UCA on intraocular pressure in mice was observed; the flash visual evoked potential of mice was compared; the changes of retinal structure, inflammation index, and oxidative stress index were observed, and autophagic protein levels were tested. Finally, the influence of UCA irradiation duration on GL symptoms was observed. The results showed that the intraocular pressure of mice decreased greatly, while their flash visual evoked potential and nervous layer of retina increased, and their ganglion cells showed stronger proliferation activity and weaker apoptosis and autophagy, indicating that UCA-mediated NGF can strongly improve the pathological condition of GL mice. In addition, PI3K/AKT pathway-associated proteins were inhibited in retina under the intervention of NGF+UCA, which further suggests that the influence of UCA-mediated NGF on GL is achieved by inhibiting autophagy of retinal ganglion cells and enhancing their apoptosis via the PI3K/AKT signaling pathway. Moreover, we found that in the treatment of GL, three weeks of UCA irradiation and six weeks caused no significant difference in the pathological manifestations and ganglion cells of mice, while after six weeks of irradiation, the level of NLRP3 in mice increased. In conclusion, UCA-mediated NGF can significantly improve the pathological condition of GL mice and improve the apoptosis of retinal ganglion cells by inhibiting autophagy, which is associated with the inhibition of the PI3K/AKT signal pathway. In terms of selection of UCA irradiation duration, three weeks of irradiation is enough to yield good clinical results.


Asunto(s)
Glaucoma/terapia , Factor de Crecimiento Nervioso/administración & dosificación , Células Ganglionares de la Retina/efectos de los fármacos , Animales , Apoptosis/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Biología Computacional , Medios de Contraste/administración & dosificación , Modelos Animales de Enfermedad , Glaucoma/patología , Glaucoma/fisiopatología , Mediadores de Inflamación/metabolismo , Presión Intraocular/efectos de los fármacos , Ratones , Ratones Endogámicos C57BL , Soluciones Oftálmicas , Estrés Oxidativo/efectos de los fármacos , Fosfatidilinositol 3-Quinasas/metabolismo , Proteínas Proto-Oncogénicas c-akt/metabolismo , Células Ganglionares de la Retina/patología , Células Ganglionares de la Retina/fisiología , Transducción de Señal/efectos de los fármacos , Terapia por Ultrasonido
4.
BMC Ophthalmol ; 20(1): 293, 2020 Jul 17.
Artículo en Inglés | MEDLINE | ID: mdl-32680481

RESUMEN

BACKGROUND: With the difficulties in IOL power calculation and the potential side effects occurring postoperatively, multifocal IOL implantation after previous corneal refractive surgery are rarely reported especially for the trifocal IOL. Herein we report the clinical observation of trifocal IOL implantation in patients with previous myopia excimer laser correction. In this study, a multi-formula average method was performed for the IOLs power calculation to improve the accuracy. Visual and refractive outcomes were analyzed, and the subjective quality of patients' life was evaluated by questionnaires survey. METHODS: This retrospective case series included patients with previous myopia excimer laser correction who underwent femtosecond laser assisted phacoemulsification and trifocal IOL (AT LISA tri 839 MP) implantation. Follow-up was done at 1-day, 1-month and 3-month to assess the visual outcomes. Outcome measures were uncorrected distance, intermediate and near visual acuity (UDVA, UIVA, UNVA), manifest refraction, defocus curve, and subjective quality of vision. RESULTS: Twenty-one Eyes from sixteen patients (14 eyes with previous laser in situ keratomileusis and 7 eyes with previous photorefractive keratectomy) were included. Mean postoperative spherical equivalent (SE) at 3-month was - 0.56 D ± 0.49 SD, wherein, 10 eyes (47.6%) were within ±0.50 D of the desired emmetropia and 19 eyes (90.5%) were within ±1.0 D. Mean monocular UDVA, UIVA and UNVA (logMAR) at last visit were 0.02 ± 0.07, 0.10 ± 0.10, and 0.15 ± 0.11 respectively. Three patients (19%) reported halos and glare in postoperative 3 months, two of them needed to use spectacles to improve the intermediate visual acuity. Fifteen patients (94%) reported a satisfaction score of ≥3.5 out of 4.0, without any difficulty in daily activity. Thirteen patients (81%) did not need spectacles at all distances, while the other 3 patients (19%) used spectacles for near-distance related visual activity. Mean composite score of the VF-14 questionnaire was 95.00 ± 7.29 out of 100. CONCLUSIONS: Trifocal IOL implantation after myopia excimer laser correction could restore good distance, intermediate visual acuity and acceptable near visual acuity, and provide accurate refractive outcomes as well as high spectacles independence rate.


Asunto(s)
Lentes Intraoculares , Miopía , Facoemulsificación , Humanos , Implantación de Lentes Intraoculares , Miopía/cirugía , Satisfacción del Paciente , Diseño de Prótesis , Refracción Ocular , Estudios Retrospectivos
5.
Int J Ophthalmol ; 3(3): 255-6, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-22553566

RESUMEN

AIM: To evaluate the availability and our experience of intraoperative image-guidance in endoscopic nasocular operation. METHODS: Seven cases of endoscopic nasal surgery with intraoperative image-guidance were retropectively reviewed, including 3 cases of optic nerve injury; 3 cases of foreign object of optic behind the eyeball; 1 case of retrobulbar tumor (angeioma). RESULTS: The preoperative preparatory time would take 15 minutes, including coordination, head holder localization, conventional instrument registration. In our cases, the localization accuracy between 3-D image landmarks of navigation system and actual anatomical landmarks was less than 1.3mm. The optic nerve and other anatomical points could be orientated accurately in intraoperative procedures. No complication occurred. CONCLUSION: Nasal endoscope combined with image-guidance systems provides accurate anatomical localization of anterior skull base with enlarged operation field. It is possible for surgeons to observe important anatomical structures during endoscopic surgery. It could increase the effectiveness and decrease surgical complications, especially in complicated cases.

6.
Yan Ke Xue Bao ; 22(4): 252-8, 2006 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-17378159

RESUMEN

PURPOSE: To examine the effect of an intravitreal injection of angiostatin on vascular leakage in retina and iris of the diabetes and study its possible mechanism. METHODS: Experimental diabetes was induced in 24 rats by an intravenous injection of streptozotocin (STZ) during 48 adult rats. Three groups were randomization distributed of them. There were 8 of both normal and diabetic rats in each group. STZ-diabetic rats and age-matched normal rats received an intravitreal injection of 5 microl of sterile PBS (Phosphate Buffered Saline) into the right eye, and the left eye was non-injected in the group A; Angiostatin was injected into the vitreous of the right eye (7.5 microg/5 microl/eye), and the left eye received the same volume of sterile PBS as the control in the group B and C. The vascular permeability of retina and iris was measured using the Evans blue method at 2 days following the injection in the group A and B. Expression of VEGF in retina was evaluated using western blot analysis 24 hours following the injection in the group C. RESULTS: Diabetic rats showed significant increases of vascular permeability in the retina (P < 0.01) and iris (P < 0.05). Angiostatin-injected eyes showed significant decreases in vascular permeability in the retina (P < 0.01) and iris (P < 0.05) comparing with the PBS-injected eyes in STZ-diabetic rats. In contrast, intravitreal injection of the same dose of angiostatin into the age-matched normal rats did not result in any significant reduction in vascular permeability in the retina and iris, when compared with the contralateral eye with PBS injection (P > 0.05). Angiostatin injection significantly reduced VEGF level in the retinas of STZ-diabetic rats but did not affect retinal VEGF level in normal rats. CONCLUSIONS: Angiostatin significantly reduce pathological vascular permeability in the retina and iris of STZ-diabetic rats but not in normal rats. Angiostatin down-regulates VEGF expression and thus, blocks the major cause of vascular leakage in the diabetic retina. Therefore, angiostatin may have a therapeutic potential in the treatment of diabetic macular edema, cystoid macular edema, uveitis and other diseases with vascular leakage.


Asunto(s)
Angiostatinas/farmacología , Permeabilidad Capilar/efectos de los fármacos , Diabetes Mellitus Experimental/patología , Retinopatía Diabética/patología , Iris/efectos de los fármacos , Vasos Retinianos/efectos de los fármacos , Animales , Inyecciones Intravítreas , Ratas , Vasos Retinianos/patología
7.
Curr Eye Res ; 30(8): 681-9, 2005 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-16109649

RESUMEN

PURPOSE: Increased retinal vascular permeability is a common complication of diabetes and a major cause of vision loss in diabetic patients. The current study is to determine the effect of plasminogen kringle 5 (K5) on vascular leakage via systemic and periocular deliveries. METHODS: Oxygen-induced retinopathy (OIR) was generated by exposing newborn rats to 75% oxygen. Diabetes was induced in adult rats by injection of streptozotocin (STZ). Retinal vascular permeability was measured by the Evans blue-albumin leakage method. RESULTS: Subcutaneous, intraperitoneal, subconjunctival, and retrobulbar injections and topical eyedrop application of K5 significantly reduced retinal vascular permeability in both the OIR and STZ-diabetic rat models. Compared with the periocular deliveries, systemic administration requires higher doses of K5. K5 deliveries downregulated VEGF expression in the retina. CONCLUSIONS: K5 can reduce retinal vascular permeability through systemic and periocular deliveries. These delivery routes of K5 have therapeutic potential in the treatment of vascular leakage.


Asunto(s)
Permeabilidad Capilar/efectos de los fármacos , Retinopatía Diabética/metabolismo , Fragmentos de Péptidos/administración & dosificación , Plasminógeno/administración & dosificación , Enfermedades de la Retina/metabolismo , Vasos Retinianos/metabolismo , Animales , Animales Recién Nacidos , Diabetes Mellitus Experimental/complicaciones , Modelos Animales de Enfermedad , Regulación hacia Abajo , Vías de Administración de Medicamentos , Técnicas para Inmunoenzimas , Oxígeno/toxicidad , Ratas , Ratas Endogámicas BN , Retina/metabolismo , Enfermedades de la Retina/inducido químicamente , Factor A de Crecimiento Endotelial Vascular/metabolismo
8.
Am J Pathol ; 166(1): 313-21, 2005 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-15632023

RESUMEN

The breakdown of the blood-retina barrier (BRB) is a common feature of diabetic retinopathy. The purpose of the present study is to determine whether there are genetic differences in susceptibility to the breakdown of the BRB in diabetic retinopathy using two rat models. In streptozotocin (STZ)-induced diabetes, Brown Norway (BN) rats developed sustained vascular hyperpermeability in the retina during the entire experimental period (16 weeks of diabetes), while diabetic Sprague Dawley (SD) rats only showed retinal hyperpermeability from 3 to 10 days after the onset of diabetes. The strain difference in permeability was not correlated with the blood glucose levels in these two strains. In oxygen-induced retinopathy (OIR), BN rats developed retinal vascular hyperpermeability from postnatal day 12 (P12) to P22 with a peak at P16, which was 8.7-fold higher than that in the age-matched normal controls. In OIR-SD rats, however, hyperpermeability was observed from P14 to P18, with a peak only 2.2-fold higher than that in the controls. The strain difference in vascular hyperpermeability was correlated with the different overexpression of vascular endothelial growth factor (VEGF) in the retina of these two models. This finding suggests that genetic backgrounds contribute to the susceptibility to diabetic retinopathy.


Asunto(s)
Sistema Cardiovascular/patología , Diabetes Mellitus Experimental/patología , Retinopatía Diabética/patología , Animales , Retinopatía Diabética/inducido químicamente , Factor I del Crecimiento Similar a la Insulina/farmacología , Oxígeno/toxicidad , Permeabilidad , Ratas , Ratas Endogámicas BN , Ratas Sprague-Dawley , Retina/efectos de los fármacos , Retina/patología , Vasos Retinianos/efectos de los fármacos , Vasos Retinianos/patología , Factor A de Crecimiento Endotelial Vascular/farmacología
9.
Invest Ophthalmol Vis Sci ; 45(6): 1758-62, 2004 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15161837

RESUMEN

PURPOSE: Human amniotic membrane (HAM) transplantation is commonly used in corneal surface reconstruction and is known to inhibit neovascularization of this tissue. The purpose of the present study is to reveal the molecular basis underlying antiangiogenic activity of HAM. METHODS: The effects of HAM protein on proliferation of vascular endothelial cells and corneal epithelial cells were determined by quantifying viable cells using the MTT assay. The presence of pigment epithelium-derived factor (PEDF) in HAM was demonstrated at the protein level by Western blot analysis and immunohistochemistry using a monoclonal antibody specific to human PEDF. The PEDF concentration was measured by a specific ELISA. The expression of PEDF in HAM was confirmed at the RNA level by RT-PCR and DNA sequencing. RESULTS: Soluble proteins from HAM inhibited proliferation of human umbilical vein endothelial cells and bovine retinal capillary endothelial cells (BRCECs) while promoting proliferation of bovine cornea epithelial cells. Moreover, the HAM-induced inhibition of BRCECs was neutralized by a specific anti-PEDF antibody. PEDF protein was identified with an abundance of 103.84 +/- 33.21 ng/mg of soluble proteins, which is comparable to that in the retina, a PEDF-rich tissue. PEDF expression was predominantly localized in the basement membrane of HAM. RT-PCR using specific PEDF primers amplified a single product from HAM RNA. The PCR product has a sequence identical with that of human PEDF. CONCLUSION: HAM specifically inhibits endothelial cell growth and thus suppresses neovascularization in the cornea. PEDF in HAM has a major role in eliciting this antiangiogenic activity.


Asunto(s)
Amnios/metabolismo , Inhibidores de la Angiogénesis/metabolismo , Neovascularización de la Córnea/prevención & control , Proteínas del Ojo , Factores de Crecimiento Nervioso , Proteínas/metabolismo , Serpinas/metabolismo , Inhibidores de la Angiogénesis/genética , Inhibidores de la Angiogénesis/farmacología , Western Blotting , División Celular/efectos de los fármacos , Endotelio Vascular/citología , Ensayo de Inmunoadsorción Enzimática , Epitelio Corneal/citología , Humanos , Técnicas para Inmunoenzimas , Proteínas/genética , Proteínas/farmacología , ARN Mensajero/metabolismo , Vasos Retinianos/citología , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Serpinas/genética , Serpinas/farmacología , Venas Umbilicales/citología
10.
FEBS Lett ; 564(1-2): 19-23, 2004 Apr 23.
Artículo en Inglés | MEDLINE | ID: mdl-15094037

RESUMEN

Angiostatin is a potent angiogenic inhibitor. The present study identified a new activity of angiostatin: reducing vascular leakage, which is associated with diabetic macular edema, tumor growth and inflammation. An intravitreal injection of angiostatin significantly reduced retinal vascular permeability in rats with oxygen-induced retinopathy and in those with streptozotocin-induced diabetes, but not in normal rats. Consistent with its effect on permeability, angiostatin downregulated vascular endothelial growth factor (VEGF) expression in the retina in both the rat models but not in normal controls. These results suggest that the effect of angiostatin on vascular leakage is mediated, at least in part, through blockade of VEGF overexpression.


Asunto(s)
Angiostatinas/farmacología , Permeabilidad Capilar/efectos de los fármacos , Vasos Retinianos/efectos de los fármacos , Factor A de Crecimiento Endotelial Vascular/biosíntesis , Inhibidores de la Angiogénesis/farmacología , Animales , Diabetes Mellitus Experimental , Retinopatía Diabética/etiología , Regulación hacia Abajo , Ratas , Retina/metabolismo
11.
Yan Ke Xue Bao ; 20(4): 206-7, 2004 Dec.
Artículo en Chino | MEDLINE | ID: mdl-15656360

RESUMEN

PURPOSE: To evaluate the effects of Naphcon eye drops for preventing conjunctival bleeding during Lasik surgery. METHODS: One hundred cases (200 eyes) were divided into treating group and control group randomly according to using and not using Naphcon eye drops before Lasik surgery. Treating group patients received three times Naphcon eye drops during 15 minutes before surgery. RESULTS: The incidence of conjunctival bleeding from treating and control group were 8% and 15% respectively. There was significant statistical difference between them. CONCLUSION: Naphcon eye drop is an effective agent to prevent conjunctival bleeding.


Asunto(s)
Hemorragia del Ojo/prevención & control , Queratomileusis por Láser In Situ , Nafazolina/uso terapéutico , Adulto , Conjuntiva , Femenino , Humanos , Masculino , Nafazolina/administración & dosificación , Soluciones Oftálmicas
12.
Cornea ; 22(5): 473-7, 2003 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-12827055

RESUMEN

PURPOSE: Pterygia are histologically composed of proliferating fibrovascular tissue. This study compared expression levels of an angiogenic inhibitor, pigment epithelium-derived factor (PEDF), in pterygia with those in normal corneal and conjunctival tissues. METHODS: The normal human conjunctival and corneal tissues were obtained from surgery or from donor eyes without ocular diseases. Pterygia were excised by therapeutic surgery under a microscope. Pigment epithelium-derived factor and vascular endothelial growth factor (VEGF) were measured by Western blot analysis. Their cellular localizations were determined by immunohistochemistry. RESULTS: Intensive PEDF immunostaining was detected in all the normal corneal and conjunctival samples analyzed, predominantly in the epithelium and endothelium of the cornea and in the epithelium of the limbus and conjunctiva. Under the same immunostaining conditions, pterygial samples showed negative or faint PEDF staining. In contrast, the same pterygial samples all showed intensive VEGF staining, predominantly in the epithelium and in blood vessels. Western blot analysis confirmed that the average PEDF level in pterygia was drastically lower than those in normal corneal and conjunctival tissues, respectively. In contrast, the VEGF level in pterygia was significantly higher than in the normal tissues. CONCLUSION: Pterygia exhibit significantly lower PEDF but higher VEGF levels than those in normal corneas and conjunctivae. The decreased PEDF level in pterygia may play a role in the formation and progression of pterygia.


Asunto(s)
Factores de Crecimiento Endotelial/metabolismo , Proteínas del Ojo , Péptidos y Proteínas de Señalización Intercelular/metabolismo , Linfocinas/metabolismo , Factores de Crecimiento Nervioso , Proteínas/metabolismo , Pterigion/metabolismo , Serpinas/metabolismo , Estudios de Casos y Controles , Humanos , Inmunohistoquímica , Factor A de Crecimiento Endotelial Vascular , Factores de Crecimiento Endotelial Vascular
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...